Adjunctive Treatment with Asenapine Augments the Escitalopram-Induced Effects on Monoaminergic Outflow and Glutamatergic Neurotransmission in the Medial Prefrontal Cortex of the Rat-Reference-Cited by-同舟云学术

Adjunctive Treatment with Asenapine Augments the Escitalopram-Induced Effects on Monoaminergic Outflow and Glutamatergic Neurotransmission in the Medial Prefrontal Cortex of the Rat

Published:2014-10-31 Issue:3 Volume:18 Page:pyu068-pyu068
ISSN:1461-1457
Container-title:International Journal of Neuropsychopharmacology
language:en
Short-container-title:International Journal of Neuropsychopharmacology

Author:

Bjorkholm C.,Franberg O.,Malmerfelt A.,Marcus M. M.,Konradsson-Geuken A.,Schilstrom B.,Jardemark K.,Svensson T. H.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

http://academic.oup.com/ijnp/article-pdf/18/3/pyu068/2070249/pyu068.pdf

Reference58 articles.

1. Serotonin Induces Excitatory Postsynaptic Potentials in Apical Dendrites of Neocortical Pyramidal Cells

2. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

3. (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex

4. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of three serotonin reuptake inhibitors on sign-tracking in male Sprague-Dawley rats;Physiology & Behavior;2023-09

2. Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism;European Neuropsychopharmacology;2022-09

3. Effects of thymoquinone in a rat model of reserpine-induced depression;Brazilian Journal of Pharmaceutical Sciences;2022

4. Asenapine in the Treatment of Psychosis;NeuroPsychopharmacotherapy;2022

5. Asenapine in the Treatment of Psychosis;NeuroPsychopharmacotherapy;2022